U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
OBEXELIMAB
USAN   INN  
Official Name English
XMAB-5871
Preferred Name English
XMAB5871 (HUMANIZED ANTI-CD19 ANTIBODY WITH AN FC PORTION ENGINEERED FOR INCREASED AFFINITY (200- TO 400-FOLD OVER NATIVE IGG) TO FCGRIIB)
Common Name English
OBEXELIMAB [USAN]
Common Name English
Obexelimab [WHO-DD]
Common Name English
XMAB5871
Code English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD19 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL XMAB5871 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL XMAB5871 LIGHT CHAIN, DIMER
Systematic Name English
obexelimab [INN]
Common Name English
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS B-LYMPHOCYTE ANTIGEN CD19 (DIFFERENTIATION ANTIGEN CD19T-CELL SURFACE ANTIGEN LEU-12))HUMANIZED MOUSE MONOCLONAL ANTIBODY.GAMMA.1 HEAVY CHAIN (1-451) (MUS MUSCULUS VH (IGHV1-14*01 (78%) (IGHD)-IGHJ4*01 (100%))
Systematic Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 566516
Created by admin on Tue Apr 01 23:26:33 GMT 2025 , Edited by admin on Tue Apr 01 23:26:33 GMT 2025
Code System Code Type Description
USAN
FG-171
Created by admin on Tue Apr 01 23:26:33 GMT 2025 , Edited by admin on Tue Apr 01 23:26:33 GMT 2025
PRIMARY
DRUG BANK
DB15032
Created by admin on Tue Apr 01 23:26:33 GMT 2025 , Edited by admin on Tue Apr 01 23:26:33 GMT 2025
PRIMARY
SMS_ID
100000183087
Created by admin on Tue Apr 01 23:26:33 GMT 2025 , Edited by admin on Tue Apr 01 23:26:33 GMT 2025
PRIMARY
INN
10898
Created by admin on Tue Apr 01 23:26:33 GMT 2025 , Edited by admin on Tue Apr 01 23:26:33 GMT 2025
PRIMARY
FDA UNII
RM16A4BA8R
Created by admin on Tue Apr 01 23:26:33 GMT 2025 , Edited by admin on Tue Apr 01 23:26:33 GMT 2025
PRIMARY
CAS
1958118-77-8
Created by admin on Tue Apr 01 23:26:33 GMT 2025 , Edited by admin on Tue Apr 01 23:26:33 GMT 2025
NO STRUCTURE GIVEN
CAS
1690307-05-1
Created by admin on Tue Apr 01 23:26:33 GMT 2025 , Edited by admin on Tue Apr 01 23:26:33 GMT 2025
PRIMARY
NCI_THESAURUS
C170236
Created by admin on Tue Apr 01 23:26:33 GMT 2025 , Edited by admin on Tue Apr 01 23:26:33 GMT 2025
PRIMARY
ACTIVE MOIETY
OBEXELIMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966